OncoPath
AI-powered cervical cancer screening validated by clinical experts, bringing life-saving technology to underserved populations worldwide.
Cervical Cancer: A Preventable Tragedy
Despite being highly preventable, cervical cancer claims 350,000 lives annually, with 90% of deaths occurring in underserved regions lacking access to quality screening programs.
The Global Cervical Cancer Burden
Global health challenge requiring immediate action
Lives that could be saved through early detection
Urgent need for accessible screening solutions
Source: World Health Organization, 2024, Cervical cancer fact sheet
Uniting Innovation with Clinical Excellence
Combining PAICON's AI technology with ETICCS' clinical expertise to create validated, scalable cervical cancer screening solutions for underserved populations worldwide.
- Advanced AI models
- Automated pathology analysis
- Colposcopy interpretation
- Secure cloud infrastructure
- 200+ cancer specialists
- 20+ years expertise
- Quality assurance frameworks
- Global validation studies
Together We Achieve More
Empowering Women
Enabling early detection and follow-up through digital tools that prioritize accessibility and care for every woman.
Global Reach
OncoPath connects women worldwide through a secure, integrated cervical cancer screening system.
Secure Health Data
Seamless communication of diagnosis, consultation, healthcare data, and telemedicine in a protected digital environment.
Unified Screening Journey
Streamlining the entire screening process from home-based data collection to lab analysis and clinical follow-up.
Connected Digital Systems
Secure sample tracking, lab analysis, and clinical care are digitally linked to eliminate data loss and ensure timely treatment.
National Health Monitoring
Aggregated health indicators support national cervical cancer programs, aligned with WHO standards for scalable impact.
The OncoPath Process
Our proven collaboration process transforms clinical expertise into scalable AI solutions, ensuring clinical validation and real-world effectiveness through a streamlined workflow designed for project success.
Registration and Legal Alignment
Establishing legal framework and compliance
Data Upload & Quality Control
Secure transfer and comprehensive quality validation
Expert Review
Clinical validation by ETiCCS experts
Annotation
Detailed clinical annotation process
AI Model Training
Advanced machine learning development
AI-Based Medical Device
Clinical deployment and integration
Digital Cervical Cancer Screening Platform
OncoPath integrates AI-powered colposcopy analysis directly into clinical workflows, helping doctors detect cervical abnormalities with greater accuracy and confidence in underserved settings worldwide.
Platform Capabilities
AI-Powered Analysis
Advanced machine learning algorithms for automated cervical image analysis
Clinical Validation
ETICCS-validated protocols ensuring clinical accuracy and reliability
Mobile Integration
Smartphone-compatible screening solutions for remote settings
Quality Assurance
Comprehensive quality control frameworks and monitoring
Transforming Global Screening Access
Accuracy Rate
Clinical-grade diagnostic accuracy validated by ETICCS experts
Expert Network
ETICCS specialists validating and improving our platform
Availability
Cloud-based platform accessible anytime, anywhere
Reach
Serving underserved populations worldwide
Explore Partnership Opportunities
Join healthcare providers, research institutions, and technology partners worldwide in our mission to democratize cancer diagnosis and bring life-saving AI tools to underserved populations.
How Partners Contribute
Clinical Data
Secure sharing of anonymized clinical images
Expert Annotation
Professional medical annotations and diagnoses
Quality Validation
Review and validate using ETICCS standards
Research Collaboration
Joint initiatives and knowledge sharing
Subscribe to Our Monthly Newsletter
Each month, we will send key data updates, stories from the field, and
new research on
inclusive oncology AI.
We respect your privacy. Unsubscribe at any time.